Pridopidine Shows Promise in Subgroup of Huntington's Patients
(MedPage Today) — SAN DIEGO — Treatment with investigational pridopidine seemed to offer benefits for certain patients with Huntington’s disease, according to subgroup analysis of the PROOF-HD trial.
Those improvements were seen in terms of…
